Successful determination of nilotinib dosage by therapeutic drug monitoring in a patient with chronic myeloid leukemia developing hepatic dysfunction: A case report-Reference-Cited by-同舟云学术

Successful determination of nilotinib dosage by therapeutic drug monitoring in a patient with chronic myeloid leukemia developing hepatic dysfunction: A case report

Published:2019-06-14 Issue:7 Volume:7 Page:1419-1421
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Nakahara Ryosuke¹^ORCID,Sumimoto Takahiro¹,Ogata Masao²,Sato Yuhki¹,Itoh Hiroki¹

Affiliation:

1. Department of Clinical Pharmacy Oita University Hospital Yufu‐shi Japan

2. Department of Hematology Oita University Hospital Yufu‐shi Japan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.2191

Reference10 articles.

1. Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

2. Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

3. Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd

4. High-performance Liquid Chromatographic Ultraviolet Detection of Nilotinib in Human Plasma from Patients with Chronic Myelogenous Leukemia, and Comparison with Liquid Chromatography-Tandem Mass Spectrometry

5. Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case series;Annals of Hematology;2024-08-12

2. A Concise Review on Analytical Methods for Determination of Nilotinib;Current Analytical Chemistry;2023-08

3. Determination of Osimertinib, Aumolertinib, and Furmonertinib in Human Plasma for Therapeutic Drug Monitoring by UPLC-MS/MS;Molecules;2022-07-13

4. Life threatening hepatotoxicity induced by Nilotinib;Journal of Oncology Pharmacy Practice;2022-06-01

5. Management of drug–drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs;The Lancet Haematology;2022-01